March 4, 2020 11:09 AM ESTUpdated January 7, 01:24 AM

Bristol-Myers joins forces with digital therapeutics co; Wearable cardioverter defibrillator scores $145M+ in Series C haul

→ Bristol-Myers Squibb has signed on digital therapeutics player Voluntis to develop a mobile app that will give cancer patients …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bris­tol-My­ers joins forces with dig­i­tal ther­a­peu­tics co; Wear­able car­diovert­er de­fib­ril­la­tor scores $145M+ in Se­ries C haul